To mark skin cancer awareness month the BMC Editors have carefully curated a collection of open access articles on this topic and there is an awareness quiz to test your melanoma knowledge.
Featured article: Pre-clinical activity of novel systemic anti-cancer therapeutic peptides
Tracy Robson and colleagues demonstrate the pre-clinical activity of FKBPL-based anti-cancer therapeutic peptides, AD-01 and ALM201, in the metastatic setting, which can specifically target tamoxifen or endocrine therapy-resistant cancer stem cells
Call for papers: Precision Oncology
We are pleased to announce a new cross-journal thematic series on ‘Precision Oncology’ across a number of BMC journals within the oncology portfolio to bring together the latest research on precision oncology. The thematic series is now open for submission of original research and review articles
Skin Cancer Awareness Month May
We are recruiting!
BMC Cancer is seeking a highly qualified individual with expertise in either clinical trials and protocol design or cancer biomarkers to serve as a Section Editor. The ideal candidate will be a well established cancer research investigator with substantial peer-review experience. Diversity in all forms will be a driving factor when selecting an individual to serve in this capacity. Please find more information and the application form here.
Articles
Featured review: Gallbladder cancer: review of a rare orphan gastrointestinal cancer with a focus on populations of New Mexico
Gallbladder cancer is a rare malignancy of the biliary tract with a poor prognosis, frequently presenting at an advanced stage. While rare in the United States overall, gallbladder cancer has an elevated incidence in geographically distinct locations of the globe including Chile, North India, Korea, Japan and the state of New Mexico in the United States. Rama R. Gullapalli, Associate Editor for BMC Cancer provides this review.
Featured review: A stepwise approach to constructing systematic reviews
Systematic reviews, with or without meta-analysis, play an important role today in synthesizing cancer research and are frequently used to guide decision-making. With a focus on cancer, first author, Prof Kelley, provides a practical, stepwise approach for systematically reviewing the literature and publishing the results.
Aims and scope
BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.
Journal Sections
- Cell and molecular biology
- Biomarkers
- Epidemiology, prevention and public health
- Experimental therapeutics and drug development
- Genetics, genomics and epigenetics
- Infection, immunity and cancer vaccines
- Medical and radiation oncology
- Surgical oncology, cancer imaging, and interventinal therapeutics
- Systems biology, post-genomic analysis and emerging technologies
- Supportive therapy, cancer burden and survivorship
Trending BMC Cancer Articles
Click here to view which Articles have been shared the most in the last month!
Featured Blog: Divide and conquer: Tackling colorectal cancer
Awareness and treatment of colorectal cancer clearly needs to improve if we are going to increase patient survival rates and allow patients to live longer with a better quality of life. Associate Editor Professor Joanne Edwards and her team at Wolfson Wohl Cancer Research Centre develope biomarkers for personalised patient care and are establishing unique patient tissue cohorts with extensive linked clinical data across a breadth of solid tumours, including colorectal cancer.
Editor
Linda Gummlich, BMC Series, London, UK
Manuscript Editor
Anne Menard, BMC Series, London, UK
Assistant Editors
Catherine Rice, Senior Assistant Editor, BMC Series, London
William Spenceley Jones, Assistant Editor, BMC Series, London
Consulting Editors
Yanis Boumber, Fox Chase Cancer Center, USA
Ken Herrmann, Universitätsklinikum Essen, Germany
Alan Lefor, Jichi Medical University, Japan
Christophe Nicot, Kansas University Medical Center, USA
Stephen Povoski, The Ohio State University, USA
Dirk Vordermark, Martin Luther University Halle-Wittenberg, Germany
Editorial: Nobel Prize Cancer Immunotherapy!
Follow Nobel Prize laureates James P. Allison's and Tasuku Honjo's footsteps and experience the genesis of a new field of cancer therapy. BMC Cancer Editorial Board Member Dr. Sheng Guo from Pittsburgh University takes us on an exciting journey of discovery...
BMC Series blog
Advertisement
Follow
2017 Journal Metrics
-
Citation Impact
3.288 - 2-year Impact Factor
3.679 - 5-year Impact Factor
1.066 - Source Normalized Impact per Paper (SNIP)
1.464 - SCImago Journal Rank (SJR)Usage
3,549,437 downloadsSocial Media Impact
2273 mentions
Advertisement
